| PERIOD ENDING | 3-Oct-09 | 4-Jul-09 | 4-Apr-09 | 31-Dec-08 | | Total Revenue | 373,963 | 362,837 | 333,052 | 418,331 | | Cost of Revenue | 153,143 | 144,154 | 127,454 | 172,063 | | | Gross Profit | 220,820 | 218,683 | 205,598 | 246,268 | | | Operating Expenses | | Research Development | 19,310 | 19,722 | 18,332 | 19,628 | | Selling General and Administrative | 102,675 | 109,583 | 99,159 | 101,464 | | Non Recurring |
-
|
-
|
-
| 6,527 | | Others | 2,723 | 2,683 | 2,616 | 2,317 | | | | Total Operating Expenses |
-
|
-
|
-
| 129,936 | | | | Operating Income or Loss | 96,112 | 86,695 | 85,491 | 116,332 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 785 | 595 | 908 | 3,066 | | Earnings Before Interest And Taxes | 96,897 | 87,290 | 86,399 | 119,398 | | Interest Expense | 2,864 | 2,649 | 3,130 | 6,987 | | Income Before Tax | 94,033 | 84,641 | 83,269 | 112,411 | | Income Tax Expense | 18,097 | 14,734 | 9,922 | 13,058 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 75,936 | 69,907 | 73,347 | 99,353 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 75,936 | 69,907 | 73,347 | 99,353 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $75,936 | $69,907 | $73,347 | $99,353 |
|
1.00% Nasdaq 
Income Statement
